Mangalam Drugs and Organics Ltd (MANGALAM):企業の財務・戦略的SWOT分析

◆英語タイトル:Mangalam Drugs and Organics Ltd (MANGALAM) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDCH202600FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Chemicals
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mangalam Drugs and Organics Ltd (MDOL) carries out manufacturing and supplying of specialty chemicals, intermediates, and active pharmaceutical ingredients. The company’s active pharmaceutical ingredients include amodiaquine HCl, bisoprolol fumarate, artemether, dihydroartemisinin, hydroxy chloroquine sulphate, furosemide, pregabalin, and lumefantrine, among others. Its intermediates comprises 4, 7 dichloroquinoline; ortho phenoxy methane sulfonanilide; tenofovir alafenamide base; and tenofovir disoproxil base. MDOL operates through its manufacturing facilities located across India. The company distributes its products through its distributors located across India. MDOL is headquartered in Mumbai, Maharashtra, India.

Mangalam Drugs and Organics Ltd Key Recent Developments

Mar 21,2021: Mangalam Drugs and Organics announces appointment of Dr. Praveen Saxena
Dec 07,2020: Mangalam Drugs and Organics : Resignation of Independent Director of the Company
Nov 21,2020: Mangalam Drugs and Organics: Change in Directorate

This comprehensive SWOT profile of Mangalam Drugs and Organics Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Mangalam Drugs and Organics Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Mangalam Drugs and Organics Ltd – Key Information
Mangalam Drugs and Organics Ltd – Overview
Mangalam Drugs and Organics Ltd – Key Employees
Mangalam Drugs and Organics Ltd – Key Employee Biographies
Mangalam Drugs and Organics Ltd – Key Operational Heads
Mangalam Drugs and Organics Ltd – Major Products and Services
Mangalam Drugs and Organics Ltd – History
Mangalam Drugs and Organics Ltd – Company Statement
Mangalam Drugs and Organics Ltd – Locations And Subsidiaries

Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Mangalam Drugs and Organics Ltd – Business Description
Mangalam Drugs and Organics Ltd – Corporate Strategy
Mangalam Drugs and Organics Ltd – SWOT Analysis
SWOT Analysis – Overview
Mangalam Drugs and Organics Ltd – Strengths
Mangalam Drugs and Organics Ltd – Weaknesses
Mangalam Drugs and Organics Ltd – Opportunities
Mangalam Drugs and Organics Ltd – Threats
Mangalam Drugs and Organics Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Mangalam Drugs and Organics Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Mangalam Drugs and Organics Ltd, Key Information
Mangalam Drugs and Organics Ltd, Key Ratios
Mangalam Drugs and Organics Ltd, Share Data
Mangalam Drugs and Organics Ltd, Major Products and Services
Mangalam Drugs and Organics Ltd, History
Mangalam Drugs and Organics Ltd, Key Employees
Mangalam Drugs and Organics Ltd, Key Employee Biographies
Mangalam Drugs and Organics Ltd, Key Operational Heads
Mangalam Drugs and Organics Ltd, Other Locations
Mangalam Drugs and Organics Ltd, Subsidiaries

Mangalam Drugs and Organics Ltd, Key Competitors
Mangalam Drugs and Organics Ltd, SWOT Analysis
Mangalam Drugs and Organics Ltd, Ratios based on current share price
Mangalam Drugs and Organics Ltd, Annual Ratios
Mangalam Drugs and Organics Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Mangalam Drugs and Organics Ltd (MANGALAM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • University of Texas MD Anderson Cancer Center:医療機器:M&Aディール及び事業提携情報
    Summary University of Texas MD Anderson Cancer Center (MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Ander …
  • Aviragen Therapeutics Inc (AVIR)-製薬・医療分野:企業M&A・提携分析
    Summary Aviragen Therapeutics Inc (Aviragen) is a pharmaceutical company that carries out anti-infective drug discovery, development and its commercialization to treat respiratory diseases. It has four product candidates in clinical development which address viral infections, namely, vapendavir, ora …
  • EnBW Energie Baden-Wurttemberg AG (EBK)-石油・ガス分野:企業M&A・提携分析
    Summary EnBW Energie Baden-Wuerttemberg AG (EnBW) is an integrated energy holding company that generates, procures, transmits and supplies electricity; and produces, transports and supplies gas through its subsidiaries. Its generation portfolio includes nuclear, coal, oil, gas, wind, and pumped stor …
  • Braxton Technologies LLC:企業の戦略・SWOT・財務分析
    Braxton Technologies LLC - Strategy, SWOT and Corporate Finance Report Summary Braxton Technologies LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Qvella Corp:医療機器:M&Aディール及び事業提携情報
    Summary Qvella Corp (Qvella) is a molecular diagnostics company which develops differentiated technology for rapid detection of pathogens causing Sepsis by direct sampling of bodily fluids. Its Field Activated Sample Treatment (FAST) -ID technology utilizes a novel electrical lysing and sample treat …
  • Strikeforce Technologies Inc (SFOR):企業の財務・戦略的SWOT分析
    Summary Strikeforce Technologies Inc (Strikeforce) is a technology company that offers cybersecurity solutions. The company offers products such as protectID, guardedID and mobiletrust. Strikeforce offers services such as information technology services, key logging and mobile security solutions, am …
  • Kforce Inc (KFRC):企業の財務・戦略的SWOT分析
    Kforce Inc (KFRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Symbiomix Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Symbiomix Therapeutics LLC (Symbiomix) is a drug development company that offers development and commercialization of novel medicines. The company offers SYM-1219, for the treatment of several serious infections in women including bacterial vaginosis. Its SYM-1219 contains secnidazole, nitro …
  • Innovent Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Innovent Biologics Inc (Innovent Biologics) is a biopharmaceutical company that discovers, develops and manufactures monoclonal antibodies. The company offers monoclonal antibodies such as IBI301, IBI302 and IBI303, among others. Its products are used for the treatment of non-Hodgkin’s lymph …
  • Hunter Engineering Co:企業の戦略的SWOT分析
    Hunter Engineering Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • The Pack Corporation
    The Pack Corporation - Strategy, SWOT and Corporate Finance Report Summary The Pack Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Kadant Inc. (KAI):企業の財務・戦略的SWOT分析
    Kadant Inc. (KAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ovensa Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ovensa Inc (Ovensa) is a preclinical stage company that develops nanotherapeutics. The company uses its proprietary Triozan Nanomedicine delivery platform that has mucosal and brain-barrier crossing properties used in treatment of oncology and neurodegenerative diseases. Its Triozan helps in …
  • Aviva Ltd.:企業の戦略・SWOT・財務分析
    Aviva Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aviva Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • H.C. Starck GmbH:企業の戦略的SWOT分析
    H.C. Starck GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Triumph Group Inc:企業の戦略・SWOT・財務情報
    Triumph Group Inc - Strategy, SWOT and Corporate Finance Report Summary Triumph Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Adocia SAS (ADOC):製薬・医療:M&Aディール及び事業提携情報
    Summary Adocia SAS (Adocia) is a biotechnology company that discovers and develops therapeutic proteins. The company provides products such as formulation of PDGF-BB for the treatment of diabetic foot ulcers. It offers novel insulin formulations for the treatment of diabetes and BioChaperone Lispro …
  • E&A Limited:企業の戦略・SWOT・財務情報
    E&A Limited - Strategy, SWOT and Corporate Finance Report Summary E&A Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Central Garden & Pet Co (CENT):企業の財務・戦略的SWOT分析
    Central Garden & Pet Co (CENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Aquila Resources Ltd:企業の戦略・SWOT・財務情報
    Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆